It should be noted that blocking the TGF-β1/Smad3 signaling pathway could inhibit the activation of Sirtuin1/p53, reduce HSC proliferation and activation, and improve the development of liver fibrosis. This evidence concerns the gene SMAD3 and Hepatic fibrosis.